Corvad as a bridge to LVAD implantation in end-stage heart disease complicated by cardiogenic shock: a three-case series - Summary - MDSpire

Corvad as a bridge to LVAD implantation in end-stage heart disease complicated by cardiogenic shock: a three-case series

  • By

  • Jianhao Hu

  • Wei Li

  • Chengxin Zhang

  • Yuyong Liu

  • May 25, 2026

  • 0 min

Share

Objective:

Consider adding context about the significance of CorVad in current treatment paradigms.

Key Findings:
  • Add numerical values for hemodynamic improvements.
Interpretation:

Mention implications for future research.

Limitations:
  • Add a point about potential biases in retrospective studies.
Conclusion:

Reiterate the importance of monitoring hemolysis in clinical practice.

Original Source(s)

Corvad as a bridge to LVAD implantation in end-stage heart disease complicated by cardiogenic shock: a three-case series

  • by Jianhao Hu, Wei Li, Chengxin Zhang, Yuyong Liu

  • May 25, 2026

Related Content

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Global evidence on the cost-effectiveness of cardiac resynchronization therapy for heart failure: a systematic review

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study